title: Rovalpituzumab tesirine and DLL3: a new challenge for small-cell lung cancer.
authors.affiliation: Division of Medical Oncology, S G Moscati Hospital, Avellino 83100, Italy. Electronic address: arossi_it@yahoo.it.
authors.forename: Antonio
authors.initials: A
authors.lastname: Rossi
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D001570:Benzodiazepinones; D002289:Carcinoma, Non-Small-Cell Lung; D006801:Humans; D018796:Immunoconjugates; D047908:Intracellular Signaling Peptides and Proteins; D008175:Lung Neoplasms; D008565:Membrane Proteins; D055752:Small Cell Lung Carcinoma
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D001570:Benzodiazepinones; C496666:DLL3 protein, human; D018796:Immunoconjugates; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; C000620223:rovalpituzumab tesirine